HALO logo
halo search icon
Enlivex Ltd.
Enlivex Ltd.
ENLV · NAS

Enlivex Ltd.

US$0.70

Price Arrow-0.001 (-0.142%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Enlivex Ltd. Overview

ENLV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ENLV

icon

Telephone

972.8.662.3301

icon

Address

14 Einstein Street, Ness Ziona, Tel Aviv 7403618

Description

Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.

ENLV Price Chart

Key Stats

Market Cap

US$167.24M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.66 - 2.1

Trade Value (12mth)

US$341,452.00

1 week

-2.23%

1 month

-19.81%

YTD

-6.68%

1 year

-28.08%

All time high

440.00

Key Fundamentals

EPS 3 yr Growth

-1701.30%

EBITDA Margin

0.00%

Operating Cashflow

-$10m

Free Cash Flow Return

-1.10%

ROIC

126.10%

Interest Coverage

NaN

Quick Ratio

193.20

Other Data

Shares Outstanding (Fully Diluted)

48m

HALO Sector

Healthcare

Next Company Report Date

23-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ENLV Announcements

Latest Announcements

DateAnnouncements
18 May 26
16 May 26
24 February 26
11 February 26
11 February 26

ENLV Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.56-0.7327.04locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.56-0.7325.48locklocklock
Growth
%locklocklocklock7.353.23,794.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Enlivex Ltd. (ENLV:NAS)?
Halo FAQ
The current share price of Enlivex Ltd. (ENLV:NAS) is USD$0.70.
What is the 52-week high share price for Enlivex Ltd. (ENLV:NAS)?
Halo FAQ
The 52-week high share price for Enlivex Ltd. (ENLV:NAS) is USD$2.10.
What is the 52-week low share price for Enlivex Ltd. (ENLV:NAS)?
Halo FAQ
The 52-week low share price for Enlivex Ltd. (ENLV:NAS) is USD$0.66.
What is the dividend yield for Enlivex Ltd. (ENLV:NAS)?
Halo FAQ
Enlivex Ltd. (ENLV:NAS) does not pay a dividend.
What was Enlivex Ltd. (ENLV:NAS) last dividend payment?
Halo FAQ
Enlivex Ltd. (ENLV:NAS) does not pay a dividend.
What is the franking level for Enlivex Ltd. (ENLV:NAS)?
Halo FAQ
Enlivex Ltd. (ENLV:NAS) has a franking level of 0.00%.
In which sector is Enlivex Ltd. (ENLV:NAS) classified?
Halo FAQ
Enlivex Ltd. (ENLV:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Enlivex Ltd. (ENLV:NAS)?
Halo FAQ
The current P/E ratio for Enlivex Ltd. (ENLV:NAS) is 0.00.

See beyond the curve.

One solution for research, investing and portfolio management.